| Display title | Medicine:Arthrogryposis–renal dysfunction–cholestasis syndrome |
| Default sort key | Arthrogryposis-renal dysfunction-cholestasis syndrome |
| Page length (in bytes) | 2,023 |
| Namespace ID | 3048 |
| Namespace | Medicine |
| Page ID | 861571 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 1 |
| Counted as a content page | Yes |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>Rtexter1 |
| Date of page creation | 01:25, 23 October 2022 |
| Latest editor | imported>Rtexter1 |
| Date of latest edit | 01:25, 23 October 2022 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | Arthrogryposis–renal dysfunction–cholestasis syndrome is a cutaneous condition caused by a mutation in the VPS33B gene. Most of the cases have been survived for infancy. Recently, College of Medical Sciences in Nepal reports a case of ARC syndrome in a girl at the age of more than 18 years. |
